臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"hong c m"的相关文件

回到依作者浏览
依题名排序	依日期排序

显示项目 26-75 / 97 (共2页)
1 2 > >>
每页显示[10|25|50]项目

机构	日期	题名	作者
臺大學術典藏	2021-09-04T05:17:00Z	Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study	Liu C.-H.; Huang Y.-J.; Yang S.-S.; Chang C.-H.; Yang S.-S.; Sun H.-Y.; Liu C.-J.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:16:58Z	Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan	Liu C.-H.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:16:48Z	Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection	Liu C.-H.; Su T.-H.; Liu C.-J.; Hong C.-M.; Yang H.-C.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:16:46Z	NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging	Su T.-H.; Liao S.-H.; Hong C.-M.; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Adhoute X.; Bourli?re M.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:16:45Z	High Level of Hepatitis B Core–Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load	Tseng T.-C.; Liu C.-J.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Huang Y.-T.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:16:33Z	Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data	Hong C.-M.; Liu C.-H.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen Y.-W.; JIA-HORNG KAO; Liu C.-J.
臺大學術典藏	2021-09-04T05:16:18Z	Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load	Tseng T.-C.; Liu C.-J.; Yang W.-T.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; Chen H.-H.; Chen P.-J.; JIA-HORNG KAO
臺大學術典藏	2021-07-12T02:44:23Z	Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data	Hong C.-M; \| Liu C.-H; \| Su T.-H; \| HUNG-CHIH YANG; \| Chen P.-J; \| Chen Y.-W; \| Kao J.-H; \| Liu C.-J.
臺大學術典藏	2021-07-03T03:33:49Z	Addition of ribavirin to daclatasvir plus asunaprevir for chronic hepatitis C 1b patients with baseline NS5A resistance-associated variants improved response	Hong C.-M.; Liu C.-J.; Yeh S.-H.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:33:42Z	A noninvasive diagnosis of hepatic fibrosis by BioFibroScore? in chronic hepatitis C patients	Liu C.-H.; Liu C.-J.; Hong C.-M.; Su T.-H.; Yang H.-C.; Chen K.-M.; Huang Y.-P.; Yeh Y.-M.; Tien H.-L.; Liu Y.-C.; Kao J.-H.; Chen D.-S.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:33:41Z	Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection	Liu C.-H.; Chen Y.-S.; Wang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:40Z	Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan	Liu C.-H.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:38Z	Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection	Liu C.-H.; Sun H.-Y.; Liu C.-J.; Sheng W.-H.; Hsieh S.-M.; Lo Y.-C.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:36Z	Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study	Liu C.-H.; Huang Y.-J.; Yang S.-S.; Chang C.-H.; Yang S.-S.; Sun H.-Y.; Liu C.-J.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:35Z	Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan	Liu C.-H.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:32Z	Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection	Liu C.-H.;Su T.-H.;Liu C.-J.;Hong C.-M.;Yang H.-C.;Tseng T.-C.;Pei-Jer Chen;Chen D.-S.;Kao J.-H.; Liu C.-H.; Su T.-H.; Liu C.-J.; Hong C.-M.; Yang H.-C.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:31Z	NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging	Su T.-H.;Liao S.-H.;Hong C.-M.;Liu C.-J.;Tseng T.-C.;Liu C.-H.;Yang H.-C.;Pei-Jer Chen;Chen D.-S.;Chen C.-L.;Adhoute X.;Bourli?Re M.;Kao J.-H.; Su T.-H.; Liao S.-H.; Hong C.-M.; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Chen C.-L.; Adhoute X.; Bourli?re M.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:29Z	High Level of Hepatitis B Core–Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load	Tseng T.-C.;Liu C.-J.;Hsu C.-Y.;Hong C.-M.;Su T.-H.;Yang W.-T.;Chen C.-L.;Yang H.-C.;Huang Y.-T.;Fang-Tzu Kuo S.;Liu C.-H.;Pei-Jer Chen;Chen D.-S.;Kao J.-H.; Tseng T.-C.; Liu C.-J.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Huang Y.-T.; Fang-Tzu Kuo S.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:23Z	Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data	Hong C.-M.; Liu C.-H.; Su T.-H.; Yang H.-C.; PEI-JER CHEN; Chen Y.-W.; Kao J.-H.; Liu C.-J.
臺大學術典藏	2021-07-03T03:33:17Z	Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load	Tseng T.-C.; Liu C.-J.; Yang W.-T.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; Chen H.-H.; PEI-JER CHEN; Kao J.-H.
臺大學術典藏	2021-06-29T06:28:12Z	Gastrointestinal complications are associated with a poor outcome in non-critically ill pneumonia patients	CHUN-TA HUANG; Hong C.-M.; Tsai Y.-J.; Sheng W.-H.; Yu C.-J.
臺大學術典藏	2021-05-31T02:57:32Z	Cross-sectional survey of women in taiwan with first-degree relatives with osteoporosis: Knowledge, health beliefs, and preventive behaviors	Chang S.-F.; Hong C.-M.; RONG-SEN YANG
臺大學術典藏	2021-05-31T02:57:16Z	Global computer-assisted appraisal of osteoporosis risk in Asian women: An innovative study	Chang S.-F.; Hong C.M.; RONG-SEN YANG
臺大學術典藏	2021-05-31T02:57:05Z	The performance of an online osteoporosis detection system a sensitivity and specificity analysis	Chang S.F.; Hong C.M.; RONG-SEN YANG
臺大學術典藏	2021-05-24T07:20:29Z	A noninvasive diagnosis of hepatic fibrosis by BioFibroScore® in chronic hepatitis C patients	CHEN-HUA LIU; Liu C.-J.; Hong C.-M.; Su T.-H.; Yang H.-C.; Chen K.-M.; Huang Y.-P.; Yeh Y.-M.; Tien H.-L.; Liu Y.-C.; Kao J.-H.; Chen D.-S.; Chen P.-J.
臺大學術典藏	2021-05-24T07:20:28Z	Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan	CHEN-HUA LIU; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-05-24T07:20:28Z	Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection	CHEN-HUA LIU; Chen Y.-S.; Wang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-05-24T07:20:27Z	Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection	CHEN-HUA LIU; Sun H.-Y.; Liu C.-J.; Sheng W.-H.; Hsieh S.-M.; Lo Y.-C.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏	2021-05-24T07:20:26Z	Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study	CHEN-HUA LIU; Huang Y.-J.; Yang S.-S.; Chang C.-H.; Yang S.-S.; Sun H.-Y.; Liu C.-J.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏	2021-05-24T07:20:25Z	Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan	CHEN-HUA LIU; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-05-24T07:20:22Z	Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection	CHEN-HUA LIU; Su T.-H.; Liu C.-J.; Hong C.-M.; Yang H.-C.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-05-24T07:20:21Z	High Level of Hepatitis B Core?�Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load	Tseng T.-C.; Liu C.-J.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Huang Y.-T.; Fang-Tzu Kuo S.; CHEN-HUA LIU; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-05-24T07:20:20Z	NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging	Su T.-H.; Liao S.-H.; Hong C.-M.; Liu C.-J.; Tseng T.-C.; CHEN-HUA LIU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Adhoute X.; Bourlière M.; Kao J.-H.
臺大學術典藏	2021-05-24T07:20:16Z	Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data	Hong C.-M.; CHEN-HUA LIU; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen Y.-W.; Kao J.-H.; Liu C.-J.
臺大學術典藏	2021-05-24T07:20:12Z	Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load	Tseng T.-C.; Liu C.-J.; Yang W.-T.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; CHEN-HUA LIU; Chen H.-H.; Chen P.-J.; Kao J.-H.
臺大學術典藏	2021-05-02T03:29:23Z	Gastrointestinal complications are associated with a poor outcome in non-critically ill pneumonia patients	Huang C.-T.;Hong C.-M.;Tsai Y.-J.;Sheng W.-H.;Chong-Jen Yu; Huang C.-T.; Hong C.-M.; Tsai Y.-J.; Sheng W.-H.; CHONG-JEN YU
臺大學術典藏	2021-04-16T07:31:05Z	Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load	Chiu H.-M.;Jen G.H.-H.;Wang Y.-W.;Fann J.C.-Y.;Hsu C.-Y.;Jeng Y.-C.;Yen A.M.-F.;Chiu S.Y.-H.;Chen S.L.-S.;Hsu W.-F.;Lee Y.-C.;Wu M.-S.;Wu C.-Y.;Jou Y.-Y.;Hsiu-Hsi Chen; Tseng T.-C.; Liu C.-J.; Yang W.-T.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; HSIU-HSI CHEN; Chen P.-J.; Kao J.-H.
臺大學術典藏	2021-04-16T07:31:05Z	Risk stratification for gastric cancer after Helicobacter pylori eradication: A population-based study on Matsu Islands	Tseng T.-C.;Liu C.-J.;Yang W.-T.;Hsu C.-Y.;Hong C.-M.;Su T.-H.;Tsai C.-H.;Chen C.-L.;Yang H.-C.;Liu C.-H.;Hsiu-Hsi Chen;Chen P.-J.;Kao J.-H.; Chiang T.-H.; Maeda M.; Yamada H.; Chan C.-C.; Chen S.L.-S.; Chiu S.Y.-H.; Chen Y.-N.; Chou Y.-H.; Shieh C.-F.; Liu C.-Y.; Chiu H.-M.; Chiang H.; Shun C.-T.; Lin M.-W.; Wu M.-S.; Lin J.-T.; HSIU-HSI CHEN; Ushijima T.; Graham D.Y.; Lee Y.-C.
臺大學術典藏	2021-03-09T01:43:24Z	Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection	Liu C.-H.; Chen Y.-S.; Wang S.-S.; Liu C.-J.; TUNG-HUNG SU; Yang H.-C.; Hong C.-M.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:24Z	A noninvasive diagnosis of hepatic fibrosis by BioFibroScore® in chronic hepatitis C patients	Liu C.-H.; Liu C.-J.; Hong C.-M.; TUNG-HUNG SU; Yang H.-C.; Chen K.-M.; Huang Y.-P.; Yeh Y.-M.; Tien H.-L.; Liu Y.-C.; Kao J.-H.; Chen D.-S.; Chen P.-J.
臺大學術典藏	2021-03-09T01:43:23Z	Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan	Liu C.-H.; Liu C.-J.; TUNG-HUNG SU; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:21Z	Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection	Liu C.-H.; Sun H.-Y.; Liu C.-J.; Sheng W.-H.; Hsieh S.-M.; Lo Y.-C.; Liu W.-C.; TUNG-HUNG SU; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:20Z	Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan	Liu C.-H.; Liu C.-J.; TUNG-HUNG SU; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:20Z	Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study	Liu C.-H.; Huang Y.-J.; Yang S.-S.; Chang C.-H.; Yang S.-S.; Sun H.-Y.; Liu C.-J.; Liu W.-C.; TUNG-HUNG SU; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:17Z	Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection	Liu C.-H.; TUNG-HUNG SU; Liu C.-J.; Hong C.-M.; Yang H.-C.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:16Z	High Level of Hepatitis B Core–Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load	Tseng T.-C.; Liu C.-J.; Hsu C.-Y.; Hong C.-M.; TUNG-HUNG SU; Yang W.-T.; Chen C.-L.; Yang H.-C.; Huang Y.-T.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:16Z	NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging	TUNG-HUNG SU; Liao S.-H.; Hong C.-M.; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Adhoute X.; Bourlière M.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:11Z	Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data	Hong C.-M.; Liu C.-H.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen Y.-W.; Kao J.-H.; Liu C.-J.
臺大學術典藏	2021-03-09T01:43:08Z	Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load	Tseng T.-C.; Liu C.-J.; Yang W.-T.; Hsu C.-Y.; Hong C.-M.; TUNG-HUNG SU; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; Chen H.-H.; Chen P.-J.; Kao J.-H.
臺大學術典藏	2021-02-26T01:59:24Z	Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection	Liu C.-H.;Sun H.-Y.;Liu C.-J.;Wang-Huei Sheng;Hsieh S.-M.;Lo Y.-C.;Liu W.-C.;Su T.-H.;Yang H.-C.;Hong C.-M.;Tseng T.-C.;Chen P.-J.;Chen D.-S.;Hung C.-C.;Kao J.-H.; Liu C.-H.; Sun H.-Y.; Liu C.-J.; WANG-HUEI SHENG; Hsieh S.-M.; Lo Y.-C.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.

显示项目 26-75 / 97 (共2页)
1 2 > >>
每页显示[10|25|50]项目

	English \| 正體中文 \| 简体中文 \| 总笔数 :2823024
	造访人次 : 30206945 在线人数 : 669 教育部委托研究计画计画执行:国立台湾大学图书馆